# Alnylam Switzerland GmbH — other, Switzerland ## Alnylam Pharmaceuticals, Inc. is the last parent traced, 1 ownership level above this company 1 ownership level above this company 0 supply relationships · 0 with suppliers, 0 with customers 0 linked facilities 0 export-control designations found 0 sovereign commitments to funds investing in this company Scrutica id org-sec-alnylam-switzerland-gmbh-ch Cite PrintScreenshot ### Ownership chain The main chain follows the strongest parent claim by confidence, source authority and date. Other named parents appear alongside it. 1. 1. Alnylam Switzerland GmbH (CH) Starting organisation. 2. 2. Alnylam Pharmaceuticals, Inc. (US)CIK 1178670 Per [SEC EDGAR](https://www.sec.gov/Archives/edgar/data/1178670/000162828026007497/alny2025q4exhibit211.htm), as of 2026-02-12 (HIGHtier 1): The SEC record names Alnylam Pharmaceuticals, Inc.; Scrutica has not confirmed it as the immediate parent. End of the displayed chain The displayed [ownership chain](https://scrutica.com/methodology#chain-of-title-walk) ends at **Alnylam Pharmaceuticals, Inc.** (CIK 1178670) Ownership diagram 1. Alnylam Switzerland GmbH (CH) 2. Alnylam Pharmaceuticals, Inc. (US) SEC EDGAR · HIGH ### Related analysis - [Headquarters country: Switzerland→ Country profile with facility capacity, government AI programmes and export-control conditions. ](https://scrutica.com/country/ch) Source coverage Geographic revenue, business segments and capital allocation are unavailable from the corporate-financial extract. The record for Alnylam Switzerland GmbH has no listing or filer identifier for matching to the corporate-financial extract. The public industry classification (SIC, NAICS) is also unrecorded. [Sources and publication limits](https://scrutica.com/methodology#licensed-substrate).